EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY 4.0

Implantable Cardioverter-Defibrillator Therapy in Contemporary Heart Failure Patients

Mehmet K Aktaş, Khawaja M Talha, Ilan Goldenberg, Wojciech Zareba, Michael Böhm, Amr Abdin, Martina Brueckmann, Cordula Zeller, Liliana Zaremba-Pechmann, Stuart Pocock, Faiez Zannad, Stefan D Anker und 4 weitere

JACC: Heart Failure · 2026-08 · 14 (8) · 103166

DOI: 10.1016/j.jchf.2026.103166 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift JACC: Heart Failure, 2026-08. Verfasst von Mehmet K Aktaş und 15 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Cardiovascular Research Center, University of Rochester, Rochester, New York, USA. Electronic address: Mehmet_Aktas@urmc.rochester.edu. Hauptthemen laut MEDLINE: Benzhydryl Compounds, Death, Sudden, Cardiac, Defibrillators, Implantable, Glucosides. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Boehringer Ingelheim Pharma GmbH und Co KG.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Benzhydryl CompoundsDeath, Sudden, CardiacDefibrillators, ImplantableGlucosidesHeart FailureSodium-Glucose Transporter 2 InhibitorsAgedFemaleHumansMaleMiddle AgedAngiotensin-Converting Enzyme InhibitorsPropensity ScoreStroke VolumeRandomized Controlled Trials as Topic

Stichwörter der Autor:innen

empagliflozinimplantable cardioverter-defibrillatormortalitysodium-glucose cotransporter 2 inhibitorsudden cardiac death

Substanzen

Angiotensin-Converting Enzyme InhibitorsBenzhydryl CompoundsempagliflozinGlucosidesSodium-Glucose Transporter 2 Inhibitors

Autor:innen und Institutionen

  • Clinical Cardiovascular Research Center, University of Rochester, Rochester, New York, USA. Electronic address: Mehmet_Aktas@urmc.rochester.edu.
  • Department of Cardiovascular Disease, Loyola University Medical Center, Maywood, Illinois, USA.
  • Clinical Cardiovascular Research Center, University of Rochester, Rochester, New York, USA.
  • Departments of Internal Medicine and Cardiology, Angiology and Intensive Care Medicine, Saarland University, Saarbrücken, Germany.
  • Boehringer Ingelheim International GmbH, Ingelheim, Germany; First Department of Medicine, Faculty of Medicine Mannheim, University of Heidelberg, Mannheim, Germany.
  • Boehringer Ingelheim International GmbH, Ingelheim, Germany.

Förderung

  • Boehringer Ingelheim Pharma GmbH und Co KG

Zitieren

APA

Aktaş, M. K., Talha, K. M., Goldenberg, I., Zareba, W., Böhm, M., Abdin, A., Brueckmann, M., Zeller, C., Zaremba-Pechmann, L., Pocock, S., Zannad, F., Anker, S. D., Filippatos, G., Butler, J., Ferreira, J. P., & Packer, M. (2026). Implantable Cardioverter-Defibrillator Therapy in Contemporary Heart Failure Patients. JACC: Heart Failure, 14(8), 103166. https://doi.org/10.1016/j.jchf.2026.103166

Vancouver

Aktaş MK, Talha KM, Goldenberg I, Zareba W, Böhm M, Abdin A, et al. Implantable Cardioverter-Defibrillator Therapy in Contemporary Heart Failure Patients. JACC: Heart Failure. 2026;14(8):103166. doi:10.1016/j.jchf.2026.103166

BibTeX
@article{Akta2026,
  author = {Aktaş, Mehmet K and Talha, Khawaja M and Goldenberg, Ilan and Zareba, Wojciech and Böhm, Michael and Abdin, Amr and Brueckmann, Martina and Zeller, Cordula and Zaremba-Pechmann, Liliana and Pocock, Stuart and Zannad, Faiez and Anker, Stefan D and Filippatos, Gerasimos and Butler, Javed and Ferreira, João Pedro and Packer, Milton},
  title = {Implantable Cardioverter-Defibrillator Therapy in Contemporary Heart Failure Patients},
  journal = {JACC: Heart Failure},
  year = {2026},
  volume = {14},
  number = {8},
  pages = {103166},
  doi = {10.1016/j.jchf.2026.103166}
}
Kostenlos starten →